BlossomHill Therapeutics completes IPO of 9.375M shares at $16.00, gross proceeds ~$150M

BlossomHill Therapeutics, Inc.

IPO closed Aug 10, 2026; 9,375,000 shares sold at $16.00 per share.
Gross proceeds approximately $150.0M before underwriting discounts and expenses.
Amended and restated certificate of incorporation and bylaws effective Aug 10, 2026.
Stock trades on Nasdaq Global Select Market under ticker BLSM.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.